Colgate-Palmolive (NYSE:CL) Position Increased by Savant Capital LLC

Savant Capital LLC raised its holdings in shares of Colgate-Palmolive (NYSE:CLFree Report) by 4.0% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 42,856 shares of the company’s stock after buying an additional 1,631 shares during the period. Savant Capital LLC’s holdings in Colgate-Palmolive were worth $3,896,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. Union Bancaire Privee UBP SA bought a new stake in Colgate-Palmolive during the fourth quarter worth approximately $32,000. Hager Investment Management Services LLC bought a new stake in Colgate-Palmolive during the fourth quarter worth approximately $36,000. Reston Wealth Management LLC bought a new stake in Colgate-Palmolive during the third quarter worth approximately $42,000. Capital Performance Advisors LLP acquired a new position in Colgate-Palmolive in the 3rd quarter worth approximately $53,000. Finally, Synergy Asset Management LLC acquired a new position in Colgate-Palmolive in the 4th quarter worth approximately $49,000. 80.41% of the stock is currently owned by institutional investors.

Colgate-Palmolive Stock Performance

NYSE:CL opened at $87.35 on Wednesday. Colgate-Palmolive has a 1 year low of $82.68 and a 1 year high of $109.30. The firm’s fifty day simple moving average is $90.14 and its 200 day simple moving average is $96.69. The company has a current ratio of 0.41, a quick ratio of 0.26 and a debt-to-equity ratio of 9.46. The firm has a market capitalization of $71.37 billion, a PE ratio of 24.82, a PEG ratio of 4.12 and a beta of 0.44.

Colgate-Palmolive (NYSE:CLGet Free Report) last posted its earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period last year, the firm posted $0.87 EPS. On average, sell-side analysts anticipate that Colgate-Palmolive will post 3.73 EPS for the current year.

Colgate-Palmolive Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be paid a $0.50 dividend. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a yield of 2.29%. Colgate-Palmolive’s payout ratio is presently 56.82%.

Wall Street Analyst Weigh In

CL has been the subject of a number of recent analyst reports. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $101.00 price objective on shares of Colgate-Palmolive in a research note on Wednesday, January 29th. Raymond James reaffirmed an “outperform” rating and issued a $105.00 price objective (down previously from $110.00) on shares of Colgate-Palmolive in a research note on Monday, February 3rd. Stifel Nicolaus decreased their price objective on shares of Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a research note on Monday, February 3rd. Wells Fargo & Company decreased their price objective on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a research note on Tuesday, January 7th. Finally, JPMorgan Chase & Co. cut their target price on shares of Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating for the company in a research report on Monday, February 3rd. One analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $101.16.

Get Our Latest Research Report on Colgate-Palmolive

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Read More

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.